Zomedica Corp. (ZOMDF): Capital Expenditures
$567.0K
Year ended 2025-12-31
$302.0K
Trailing 12 months to 2026-06-30
-10.4%
3-year compound annual growth
+107.2%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $567.0K | -89.1% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $5.21M | -54.0% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $11.34M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $787.0K | +435.4% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $147.0K | +889.9% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $14.8K | -90.5% | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $155.5K | -75.2% | 2021-02-26, From 2019-01-01 |
| 2018-12-31 | $628.0K | +265.7% | 2020-02-26, From 2018-01-01 |
| 2017-12-31 | $171.7K | -25.8% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $231.6K | n/a | 2018-02-28, From 2016-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $567.0K | -89.1% |
| Verastem, Inc. (VSTM) | 2024-12-31 | $28.0K | n/a |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $50.0K | -94.5% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $2.35M | -16.9% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $0 | -100.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $756.6K | +0.5% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $174.5K | -89.5% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $121.6K | -61.2% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $177.0K | +168.2% |
Compare ZOMDF, VSTM, FHTX, BHST side by side · Screen every company in Pharmaceutical Preparations ↗